Rodger Novak is President at CRISPR Therapeutics AG (CRSP). They have made 40 open-market trades across 1 company since 2017, most recently 2021-06-30.
CIK 0001682017
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 40 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRSP | 573,007 | $28.2M |
Shares reported on the most recent Form 4, priced at the 2021-07-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRSP | SELL | 2021-06-30 | 2021-07-01 | $165.00 | $4.1M | -16.7% | -21.8% | -29.5% |
| CRSP | SELL | 2021-06-28 | 2021-06-30 | $156.55 | $7.8M | -15.9% | -24.9% | -30.4% |
| CRSP | SELL | 2021-06-21 | 2021-06-23 | $128.62 | $6.4M | +12.0% | -7.5% | -11.3% |
| CRSP | SELL | 2020-11-30 | 2020-12-02 | $125.00 | $6.3M | +14.0% | +20.1% | -1.4% |
| CRSP | SELL | 2020-10-08 | 2020-10-13 | $100.00 | $2.5M | -10.8% | -2.1% | +81.8% |
| CRSP | SELL | 2020-09-01 | 2020-09-03 | $92.62 | $4.6M | -1.0% | +0.3% | +52.1% |
| CRSP | SELL | 2020-08-19 | 2020-08-21 | $100.00 | $2.5M | +2.7% | -7.1% | +19.4% |
| CRSP | SELL | 2020-07-07 | 2020-07-09 | $90.00 | $2.3M | +0.1% | -2.8% | +4.5% |
| CRSP | SELL | 2020-07-01 | 2020-07-06 | $80.00 | $4.0M | +8.3% | +12.0% | +2.8% |
| CRSP | SELL | 2020-06-23 | 2020-06-25 | $75.00 | $3.8M | +24.4% | +21.7% | +11.9% |
| CRSP | SELL | 2020-05-22 | 2020-05-27 | $70.20 | $7.0M | -4.9% | +16.3% | +39.7% |
| CRSP | SELL | 2020-05-19 | 2020-05-21 | $65.00 | $3.3M | -3.7% | +6.8% | +49.2% |
| CRSP | SELL | 2019-11-19 | 2019-11-21 | $70.00 | $2.4M | +21.3% | +14.2% | -2.2% |
| CRSP | SELL | 2019-07-10 | 2019-07-12 | $50.00 | $2.5M | +0.1% | -0.3% | -25.0% |
| CRSP | SELL | 2019-06-10 | 2019-06-12 | $45.00 | $2.3M | -0.7% | +12.5% | +5.8% |
| CRSP | SELL | 2019-03-04 | 2019-03-05 | $40.37 | $2.9M | -5.4% | -6.6% | -11.9% |
| CRSP | SELL | 2019-03-01 | 2019-03-05 | $40.01 | $348K | -5.4% | -6.6% | -11.9% |
| CRSP | SELL | 2019-03-01 | 2019-03-05 | $40.37 | $6.7M | -5.4% | -6.6% | -11.9% |
| CRSP | SELL | 2019-02-25 | 2019-02-27 | $40.00 | $591K | +5.9% | -3.1% | -0.4% |
| CRSP | SELL | 2019-01-08 | 2019-01-10 | $35.02 | $7.0M | -8.7% | -9.5% | +12.9% |
| CRSP | SELL | 2018-05-17 | 2018-05-21 | $60.00 | $4.5M | +3.3% | +0.4% | -24.7% |
| CRSP | SELL | 2017-09-05 | 2017-09-05 | $20.33 | $78K | -2.7% | -2.7% | -7.4% |
| CRSP | SELL | 2017-08-31 | 2017-09-05 | $20.76 | $767K | -2.7% | -2.7% | -7.4% |
| CRSP | SELL | 2017-08-31 | 2017-09-05 | $20.87 | $305K | -2.7% | -2.7% | -7.4% |
| CRSP | SELL | 2017-08-30 | 2017-08-30 | $20.31 | $1.2M | -9.5% | -14.5% | -8.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.